
Alpha Cognition Secures U.S. Patent for ALPHA-1062 Targeting Traumatic Brain Injury Treatment
Alpha Cognition Secures U.S. Patent for ALPHA-1062 in Traumatic Brain Injury, Expanding Pipeline Potential Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, has…












